NFKB1 and neoplasm: The latter finding implicating growth and metastasis of the tumor population in CSCs to be driven by HER2 and uPAR mediated by NF-κB may partially explain the failure of existing treatment strategies to completely eradicate solid tumors [107] and drug resistance.